Invert

📍 San Francisco, United States👥 47 employees💰 Last funded Nov 2021
Biotechnology Research🌐 invertbio.com
Website LinkedIn
Invert is Bioprocess AI Software that transforms fragmented data into a living knowledge base – one that gets smarter with every run, batch, and experiment. By connecting data across instruments, systems, and CDMOs, Invert delivers the compounding scientific intelligence teams need to make faster, more confident decisions and bring life-changing therapies to market sooner. Biotech, pharma, and manufacturing companies around the world rely on Invert to reduce uncertainty, accelerate development and scale-up, and deliver life-saving therapies and sustainable products faster.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Denmark
1
Frequently asked questions
Who invested in Invert?
Invert has 2 investors on record on gritt.io.
When did Invert last raise funding?
The most recent investment in Invert recorded on gritt.io was in November 2021.
What industry is Invert in?
Invert operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Invert based?
Invert is headquartered in San Francisco, United States.